VP of Global Regulatory Affairs

US (Remote)
Role Details
Position
VP of Global Regulatory Affairs
Function
Clinical
Location
US (Remote)
Reports To
Chief Medical Officer

About the Job

The VP Global Regulatory Affairs is accountable for the integrated worldwide regulatory strategy, leadership, and delivery for the company’s pipeline of therapies targeting immune-mediated diseases. This executive will establish a globally coherent strategy while addressing country- and region-specific requirements across U.S., China, Asia-Pacific, Europe, and other priority regions.

The role is responsible for planning and executing INDs, CTAs, and related submissions; guiding first-in-human and early clinical development regulatory strategies; and defining the path through proof-of-concept, later-stage development, marketing authorization, and lifecycle management.

The role requires deep expertise in global drug development regulations, strong scientific and regulatory judgment, and the ability to drive high-quality execution across multiple geographies, cultures, and health-authority frameworks. This leader will build a world-class Global Regulatory Affairs function and ensure coordinated global and regional execution.

Working through cross-functional and regional development teams, the VP Global Regulatory Affairs will provide unified regulatory leadership across the portfolio. This executive will integrate scientific, medical, clinical, CMC, safety, translational, commercial, and market-access considerations into coherent global strategies and executable regional plans.

These plans will align with each program’s vision, Target Product Profile, and value proposition; establish the optimal sequence of submissions across priority markets; define clear global and regional objectives, decision criteria, and accountabilities; identify and mitigate critical risks and dependencies; and support timely, evidence-based decisions at key investment, submission, and governance milestones.

The VP Global Regulatory Affairs will lead by influence across functions and geographies. They will create a high-performing Global Regulatory Affairs team with clear global and regional accountabilities, transparent decision-making, and strong execution discipline.

This leader will work closely with Research, Pre-clinical Development, Clinical Development, Clinical Operations, Translational Medicine, Biomarkers, Clinical Pharmacology, CMC, Safety, DMPK, Quality, Project Management, Finance, and Business Development; align regional regulatory leads and external representatives; represent regulatory strategy at senior governance forums and with partners; and serve as a senior company representative in interactions with FDA, NMPA, EMA, and other health authorities worldwide.

This role reports to the Chief Medical Officer.

Key Responsibilities

Global Regulatory Strategy & Leadership

  • End-to-End Strategy: Define and drive global regulatory strategies from candidate selection, IND/CTA-enabling work, FIH, Phase 1b PoM, Phase 2a PoC, through later-stage development, registration, and lifecycle management.
  • Cross-Functional Alignment: Partner across Research, Clinical Development/Ops, Translational Science, CMC, Safety, and Quality to bridge evidence gaps and align strategy.
  • Innovative Design: Guide decisions on indications, endpoints, biomarkers, dose, expedited pathways, and adaptive, basket, platform, or decentralized trial approaches.
  • Governance: Direct global and regional regulatory teams; document uncertainties, risks, agency commitments, and success criteria for portfolio decisions.

Team & Organizational Leadership

  • Capability Building: Build a scalable early-stage biotech regulatory team and operating model, effectively managing internal staff, vendors, publishers, and local agents.
  • Quality & Compliance: Embed ICH, GLP/GMP/GCP, data integrity, and inspection readiness into operating procedures, document controls, and record-keeping.

Submissions & Health Authority Engagement

  • Submission Ownership: Lead global IND/CTA filings, trial applications/amendments, briefing packages, expedited requests, and marketing applications (MAA/BLA/NDA) with clear timelines and quality oversight.
  • Health Authority Leadership: Lead interactions and negotiations with the FDA, EMA, NMPA, and other major health authorities; direct meeting preparation, document outcomes, and translate feedback into actionable program commitments.
  • Regulatory Readiness: Translate nonclinical, CMC, clinical, and safety data into robust regulatory positions, ensuring supply and manufacturing readiness (GMP/labeling/packaging).

Development, Evidence & Registration

  • Decision-Quality Evidence: Shape trial designs to generate evidence supporting safety, PK/PD, target engagement, benefit-risk, and registration pathways.
  • Document Oversight: Oversee regulatory aspects of protocols, investigator brochures, study reports, informed consent, and safety reporting to ensure global compliance.
  • Registration Pathway: Maintain clear registration pathways addressing pediatric requirements, post-approval obligations, labeling, and commercialization strategies.

Regulatory Operations, Planning & Risk Management

  • Program Planning: Own global regulatory timelines, dependencies, outsourcing, and budgets; align regional submission sequencing with overall corporate priorities.
  • Risk & Compliance: Identify scientific, CMC, safety, operational, and regulatory risks early; establish contingency plans and escalate critical issues.

Stakeholder Communication & BD Support

  • Representation: Serve as primary regulatory spokesperson internally (to senior leadership) and externally (health authorities, partners, KOLs).
  • Business Development: Support financing, licensing, and BD due diligence with regulatory feasibility, risk, and value assessments.

Qualifications, Education & Experience

Essential

  • Education: MD, PhD, PharmD, or advanced degree in relevant scientific/medical discipline. Strong expertise in immunology, inflammation, or rare diseases.
  • Experience: 7–10+ years in Global Regulatory Affairs (biotech/pharma), with proven leadership advancing immunology/rare disease programs from preclinical through IND/CTA, FIH, Phase 2 PoC, and beyond.
  • Regulatory Authority Mastery: Track record of leading complex global submissions and negotiations with FDA (essential) and working knowledge of EMA, NMPA, and ICH guidelines.
  • Broad Drug Development Knowledge: Comprehensive understanding across biologics and oral therapeutics (nonclinical, CMC, clinical pharmacology, safety, biomarkers).
  • Strategic Execution: Proven ability to navigate complex pathways, leverage expedited programs, translate data into strategic choices, and operate effectively in a fast-paced biotech environment.

Leadership Profile

  • Combines scientific depth, strategic vision, and hands-on regulatory execution. A decisive leader who translates complex technical data and evolving health authority policies into clear development pathways, navigates risk collaboratively, and builds high-performing global teams.

Preferred Qualifications

  • Domain experience in respiratory, dermatology, rheumatology, or gastroenterology indications.
  • Experience advancing programs past PoC into global authorization, approval, and product launch.
  • Multiregional experience managing submissions and execution across the US, China, Europe, and other key markets.
  • Development experience with next-gen biologics (bispecifics/multispecifics, antibodies) and oral modalities.
  • Experience building regulatory infrastructure and conducting BD/licensing due diligence.

Skills & Competencies

Additional Information

The Company

Ailux is an innovative biotechnology company harnessing AI to accelerate breakthrough biologic therapies in difficult immune-mediated diseases and improve the lives of patients with significant unmet medical need.

Built on intelligent design and guided by people who care about transforming healthcare, our technology is redefining what is possible in biologics development, from how we select targets to how we engineer the molecules.Ailux’s vision is to light the path to new cures and fundamentally change our approach to science and drug development to redefine current treatment paradigms.

We look to continue unlocking the potential of disease biology, integrate AI-enabled biologics development, and deliver effective clinical execution.Backed by an experienced leadership team, leading scientific advisors, a highly multidisciplinary organization, and strategic partnerships in biopharma, Ailux is approaching a key inflection point as its first wave of therapeutic programs advance toward clinical development.

This is an opportunity to play a vital role in leading programs from pre-clinical development into the clinic and through clinical proof-of-concept, shaping the pipeline and development culture of a rapidly growing biotechnology company.

Ideal Candidate Profile